Gregory A. Otterson
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(US)The Ohio State University Wexner Medical Center(US)The Ohio State University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden(2018)3,112 cited
- → Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial(2015)1,421 cited
- → Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,384 cited
- → Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology(2017)1,322 cited
- → NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020(2019)999 cited
- → NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021(2021)996 cited